Antioxidants attenuate nuclear factor-kappa B activation and tumor necrosis factor-alpha production in alcoholic hepatitis patient monocytes and rat Kupffer cells, in vitro

Clinical Biochemistry

Volumn 32, Issue 7, 1999, Pages 563-570

  Hill, Daniell B ^a   Devalaraja, Radhika ^a   Joshi Barve, Swati ^a   Barve, Shirish ^a   McClain, Craig J ^a,b  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b LEXINGTON VA MEDICAL CENTER   (United States)

Author keywords

Alcoholic liver disease; Antioxidants; Cytokines; Glutathione; Nuclear factor kappa B; Tumor necrosis factor

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL SUCCINATE; ANTIOXIDANT; BUTYLATED HYDROXYANISOLE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ALCOHOL LIVER DISEASE; ANIMAL CELL; ANTIOXIDANT ACTIVITY; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; ELECTROPHORETIC MOBILITY; HEPATITIS; HUMAN; HUMAN CELL; KUPFFER CELL; MALE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIOXIDANTS; GLUTATHIONE; HEPATITIS, ALCOHOLIC; HUMANS; KUPFFER CELLS; MALE; MONOCYTES; NF-KAPPA B; RATS; RATS, SPRAGUE-DAWLEY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033407588     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(99)00056-9     Document Type: Conference Paper

References (50)

1. Tracey K.J., Lowry S.F. The role of cytokine mediators in septic shock. Adv Surg. 23:1990;21-67.
2. Sherry B., Cerami A. Cachectin/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of inflammatory response. J Cell Biol. 107:1988;1269-1274.
3. Shedlofsky S.I., McClain C.J. Hepatic dysfunction due to cytokines. Kimball E.S. Cytokines and inflammation. 1991;235-273 CRC Press, Inc, Boca Raton, FL.
4. McClain C.J., Hill D.B., Schmidt J., Diehl A.M. Cytokines and alcoholic liver disease. Semin Liver Dis. 13:1993;170-182.
5. Hill D., Shedlofsky S., McClain C., Diehl A.M., Tsukamoto H. Cytokines and liver disease. Remick D.G., Friedland J.S. Cytokines in health and disease. 1997;401-425 Marcel Dekker, Inc, New York, NY.
6. Hill D.B., Deaciuc I.V., Nanji A.A., McClain C.J. Mechanisms of hepatic injury in alcoholic liver disease. Clin Liver Dis. 2:1998;703-721.
7. Beese E.J., Michie C.A., Nicholls S.W., et al. Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease. Gastroenterology. 106:1994;1455-1466.
8. Targan S.R., Hanauer S.R., van Deventer S.J.H., et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor α for Crohn's disease. N Engl J Med. 337:1997;1029-1035.
9. Iimuro Y., Gallucci R.M., Luster M.I., Kono H., Thurman R.G. Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat. Hepatology. 26:1997;1530-1537.
10. Akerman P., Cote P., Yang S.Q., et al. Antibodies to tumor necrosis factor-alpha inhibit liver regeneration after partial hepatectomy. Am J Physiol. 263:1992;G579-G585.
11. Freudenberg MA, Kepller D, Galanos C. Requirement for lipopolysacharide-sensitive macrophages in galactoseamine-induced sensitization to endotoxin. 1986; 79: 891-902.
12. Nathan C.F. Secretory products of macrophages. J Clin Invest. 79:1987;319-322.
13. Takemura R., Zena W. Secretory products of macrophages and their physiologic functions. Am J Physiol. 249:1984;C1-C9.
14. Karck U., Peters T., Decker K. The release of tumor necrosis factor from endotoxin-stimulated rat Kupffer cells is regulated by prostaglandinE2 and dexamethosone. J Hepatol. 7:1988;352-361.
15. Darlington G.J., Wilson D.R., Lachman L.B. Monocyte conditioned medium, IL-1 and TNF stimulate the acute phase response in human hepatoma cell in vitro. J Cell Biol. 103:1985;787-793.
16. Nagakawa J., Hishinuma I., Hirota K., et al. Involvement of tumor necrosis factor in the pathogenesis of activated macrophages-mediated hepatitis. Gastroenterology. 99:1990;758-765.
17. McClain C.J., Cohen D.A. Increased tumor necrosis factor production by monocytes in alcoholic hepatitis. Hepatology. 9:1989;349-351.
18. Schreck R., Rieber P., Baeuerle P.A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. Embo J. 10:1991;2247-2258.
19. Schultze-Osthoff K., Los M., Baeuerle P. Redox signaling by transcription factors NF-κB and AP-1 in lymphocytes. Biochem Pharmacol. 50:1995;735-741.
20. Maddrey W.C., Boitnott J.K., Marshall S., et al. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology. 75:1978;193-199.
21. Mendenhall C.L., Anderson S., Garcia-Pont P., et al. Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone. N Engl J Med. 311:1984;1464-1470.
22. Hill D.B., Marsano L., Cohen D., Allen J., Shedlofsky S., McClain C.J. Increased plasma interleukin-6 concentrations in alcoholic hepatitis. J Lab Clin Med. 119:1992;547-552.
23. McClosky T.W., Todaro J.A., Laskin D.L. Lipopolysacharide treatment of rats alters antigen expression and oxidative metabolism in hepatic macrophages and endothelial cells. Hepatology. 16:1992;191-203.
24. Kramer S.M., Carver M.E. Serum free invitro bioassay for the detection of tumor necrosis factor. J Immunol Methods. 93:1986;201-206.
25. Dignam J.D., Libowitz R.M., Roeder R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1983;1475-1489.
26. Makhatadze N.J. Tumor necrosis factor locus genetic organisation and biological implications . Hum Immunol. 59:1998;571-579.
27. Keystone E.C. The role of tumor necrosis factor antagonism in clinical practice. J Rheumatol. 26:1999;22-28.
28. Present D.H., Rutgeerts P., Targan S., et al. Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med. 6:1999;1398-1405.
29. Weinblatt M.E., Kremer J.M., Bankhurst A.D., et al. A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med. 340:1999;253-259.
30. Bode C., Kugler V., Bode J.C. Endotoxemia in patients with alcoholic and nonalcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess. J Hepatol. 4:1987;8-14.
31. Mendez C., Garcia I., Maier R.V. Antioxidants attenuate endotoxin-induced activation of alveolar macrophages. Surgery. 118:1995;412-420.
32. Honchel R., Ray M.B., Marsano L. Tumor necrosis factor in alcohol enhanced liver injury. Alcohol Clin Exp Res. 16:1992;665-669.
33. Kamamura S., Tsukamoto H. Cytokine gene expression by Kupffer cells in experimental alcoholic liver disease. Hepatology. 22:1995;1304-1309.
34. Yagisawa M., Saeki K., Okuma E., et al. Signal transduction pathways in normal human monocytes stimulated by cytokines and mediators Comparative study with normal human neutrophils or transformed cells and the putative roles in functionality and cell biology . Exp Hematol. 27:1999;1063-1076.
35. Adachi Y., Bradford B.U., Gao W., Bojes H.K., Thurman R.G. Inactivation of Kupffer cells prevents early alcohol-induced liver injury. Hepatology. 20:1994;453-460.
36. Henderson A., Hayes P. Acetylcysteine as a cytoprotective antioxidant in patients with severe sepsis Potential new use for an old drug . Ann Pharmcother. 28:1994;1086-1088.
37. Inoue M. Protective mechanism against reactive oxygen species. Arias I.M., Boyer J.L., Jakoby W.B., Fausto N., Schacter D., Shafritz Eds. The liver biology and pathobiology. 1994;443-459 Raven, New York.
38. Fox E.S., Brower J.S., Bellezzo J.M., Leingang K.A. N-acetylcysteine and α-Tocopherol reverse the inflammatory response in activated rat Kupffer cells. J Immunol. 15:1997;5418-5423.
39. Yao T., Degli Esposti S., Huang L., Arnon R., Spangenberger A., Zern M.A. Inhibition of carbon tetrachloride-induced liver injury in liposomes containing vitamin E. Am J Physiol. 267:1994;G476-G484.
40. Liu S.L., Esposti D., Yao T., Diehl A.M., Zern M.A. Vitamin E therapy of acute CC14-induced hepatic injury in mice is associated with inhibition of nuclear factor kappa B binding. Hepatology. 22:1995;1474-1481.
41. Mullen K.D., Dasarathy S. Potential new therapies for alcoholic disease. Clinics in Liver Disease. 2:1998;851-881.
42. De la Mazza M.P., Petermann M., Bunout D., et al. Effects of long-term vitamin E supplementation in alcoholic cirrhotics. J Am Coll Nutr. 14:1995;192-196.
43. Rubin R.A., Herrine S.K., Zerin M.A. Treatment of alcoholic hepatitis with d-α-tocopherol, polyethylene glycol 1000 succinate. Gastroenterology. 110:1996;A1308.
44. Pena L.R., Hill D.B., McClain C.J. Treatment with glutathione precursor decreases cytokine activity. JPEN. 23:1999;1-6.
45. Bautista A.P., Meszaros K., Bojta J., Spitzer J.J. Superoxide anion generation in the liver during the early stage of endotoxemia in rats. J Leukocyte Biol. 48:1990;123-128.
46. Jaeschke H., Farhood A., Bautista A.P., Spolarics Z., Spitzer J.J. Complement activates kupffer cells and neutrophils during reperfusion after hepatic ischemia. Am J Physiol. 264:1993;G801-G809.
47. Spolarics Z. Endotoxin stimulates gene expression of ROS-eliminating pathways in rat hepatic endothelial and Kupffer cells. Am J Physiol. 270:1996;G660-G666.
48. Wong G.H.W., Elwell J.H., Oberley L.W., Goeddel D.V. Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell. 58:1989;923-931.
49. Perera C., St. Clair D., McClain C.J. Differential regulation of manganese superoxide dismutase activity by alcohol and TNF in human hepatoma cells. Arch Biochem Biophys. 323:1995;471-476.
50. Hamada E., Nishida T., Uchiyama Y., et al. Activation of Kupffer cells and caspase-3 involved in rat hepatocyte apoptosis induced by endotoxin. J Hepatology. 30:1999;807-818.